Document Leak: NICE Says No to MS

London-Schering and Biogen have both expressed anger over the leak of a National Institute of Clinical Excellence (NICE) document suggesting that doctors stop prescribing beta-interferon to new multiple sclerosis (MS) patients.

Related Content:

Pharmaceutical Executive-09-01-2001

Profits and Promotion Under Attack

Church and State

Business Disposal: GSK Dumps Affymax